AMMONIA OXIDIZING MICROORGANISMS FOR USE AND DELIVERY TO THE GASTROINTESTINAL SYSTEM

METHOD FOR ENHANCING EXPRESSION OF INSULIN LIKE GROWTH FACTOR 1 RECEPTOR IN UMBILICAL CORD MESENCHYMAL STEM CELL AND METHOD FOR OBTAINING MULTIPOTENT UMBILICAL CORD MESENCHYMAL STEM CELL

COMPOSITIONS INCLUDING KILLER INNATE-LIKE T CELLS AND USES THEREOF

PROPHYLAXIS AND THERAPY FOR OCULAR DISEASES LEADING TO BLINDNESS

COMPOSITIONS FOR AND METHODS OF TREATING, PREVENTING, AND/OR MITIGATING PAIN

Compositions And Methods For Inducing Apoptosis In Anaerobic Cells And Related Clinical Methods For Treating Cancer And Pathogenic Infections

COMPOSITIONS AND METHODS FOR COVID-19 TREATMENT

IMMUNOMODULATORY LIPIDS AND USES THEREOF

IMIDAZOLATE GOLD COMPOUNDS FOR THE TREATMENT OF LUNG CANCER

COMPOSITIONS FOR VITAMIN D PRODUCTION

BROMODOMAIN INHIBITORS

ANTI-CORONAVIRUS EFFECT AND APPLICATION OF P14K INHIBITOR

METHOD FOR TREATING CANCER

Diketopiperazine Microparticles with Defined Specific Surface Areas

TREATMENT OF CELL PROLIFERATION-ASSOCIATED CONDITIONS USING A COMBINATION OF A CLB-B INHIBITOR AND AN ADDITIONAL THERAPEUTIC AGENT

METHODS OF TREATING COMPLEX REGIONAL PAIN SYNDROME

EFFECTS OF LYSERGIC ACID DIETHYLAMIDE (LSD) AND OF LSD ANALOGS TO ASSIST PSYCHOTHERAPY FOR GENERALIZED ANXIETY DISORDER OR OTHER ANXIETY NOT RELATED TO LIFE-THREATENING ILLNESS

Compositions to Enhance and Extend Quality of Life

DELIVERY OF AN ANTIOXIDANT COMPOUND FOR TREATING SEIZURES, VIRAL INFECTIONS, EXPOSURE TO CHEMICAL WARFARE AGENTS, AND OTHER CONDITIONS

Novel Beta-Alanine Compositions and Methods of Use Thereof

INHIBITORS OF AUTOPHAGY AND DCAR-1 AS NOVEL ANTHELMINTIC AGENTS

THERAPEUTIC COMBINATIONS OF COLCHICINE AND METHODS OF USING SAME

USE OF CANNABIDIOL IN THE TREATMENT OF EPILEPSY

PHARMACEUTICAL DOSAGE FORM FOR APPLICATION TO MUCOUS MEMBRANES

NITROGEN-BRANCHED NON-LINEAR PEGYLATED LIPID CONTAINING A TERTIARY AMINE AND APPLICATION THEREOF

LIPIDS AND LIPID NANOPARTICLE FORMULATIONS

METHODS FOR OVERCOMING TAZEMETOSTAT-RESISTANCE IN CANCER PATIENTS

USE OF TUMOR MUTATIONAL BURDEN AS A PREDICTIVE BIOMARKER FOR IMMUNE CHECKPOINT INHIBITOR VERSUS CHEMOTHERAPY EFFECTIVENESS IN CANCER TREATMENT

NOVEL ESTROGEN RECEPTOR MUTATIONS AND USES THEREOF

BIOCATALYST AND METHODS FOR SYNTHESIZING MIXED DISULFIDE CONJUGATES OF THIENOPYRIDINE COMPOUNDS

TRANS-SPLICING RNA (TSRNA)

ENHANCED IMMUNE EFFECTOR CELLS AND USE THEREOF

LINKER FOR ANTIBODY-DRUG CONJUGATES AND ITS USE

NOVEL INTERFERON VARIANTS AND BIFUNCTIONAL FUSION MOLECULES THEREOF

HETERODIMERIC POLYPEPTIDE COMPLEXES COMPRISING IL-15 VARIANTS AND USES THEREOF

PYRAZOLOPYRIMIDINE DERIVATIVE AND ANTICANCER PHARMACEUTICAL COMPOSITION CONTAINING SAME AS ACTIVE INGREDIENT

METHODS OF PREPARING HETEROARYL-KETONE FUSED AZADECALIN GLUCOCORTICOID RECEPTOR MODULATORS

SIGMA-2 RECEPTOR LIGAND DRUG CONJUGATES AS ANTITUMOR COMPOUNDS, METHODS OF SYNTHESIS AND USES THEREOF

2-((4-((S)-2-(4-CHLORO-2-FLUOROPHENYL)-2-METHYLBENZO[D][1,3]DIOXOL-4-YL)PIPERIDIN-1-YL)METHYL)-1-(((S)-OXETAN-2-YL)METHYL)-1H-IMIDAZOLE DERIVATIVES AS ACTIVATORS OF THE GLP1 RECEPTOR FOR THE TREATMENT OF OBESITY

HETEROCYCLIC GLP-1 AGONISTS

UBIQUITIN SPECIFIC PROCESSING PROTEASE 1 (USP1) COMPOUNDS

PYRIDINE DERIVATIVE AND USE THEREOF

SOLID FORM OF A BRADYKININ B2-RECEPTOR ANTAGONIST

LIPID COMPOUNDS AND LIPID NANOPARTICLE COMPOSITIONS

COMPOSITION FOR PREVENTING, ALLEVIATING OR TREATING CANCER

CRYSTALLINE BUFOTENIDINE COMPOUNDS

MODULAR BETARETROVIRUS RECEPTOR ATTACHMENT AND CELL ENTRY PROTEINS

Methods Of Treatment Of Pterygium Using An Anti-VEGF Agent

THERAPEUTIC ACID CERAMIDASE COMPOSITIONS AND METHODS OF MAKING AND USING THEM

NOVEL THERAPEUTIC USES OF GARDNERELLA ENDOLYSINS

COMPOSITIONS AND METHODS FOR TARGETING NUCLEAR IMPORT SHUTTLES AND TREATING INFLAMMATORY DISORDERS

COMPOSITIONS AND METHODS FOR PROMOTING AND MAINTAINING ORAL HEALTH

GLYCAN STRANDS AND OLIGOSACCHARIDES DERIVED FROM STREPTOCOCCUS BACTERIA

ALLOGRAFT TOLERANCE WITHOUT THE NEED FOR SYSTEMIC IMMUNE SUPPRESSION

INTERACTION OF FIBROBLASTS AND IMMUNE CELLS FOR ACTIVATION AND USES THEREOF

PREPARATION METHOD OF PHARMACEUTICAL COMPOSITION FOR TREATING CHRONIC STROKE

Therapeutic Composition and Methods

COLESTYRAMINE FOR TREATING WOUNDS, BACTERIAL INFECTIONS OF THE SKIN, AND INFLAMMATORY SKIN LESIONS

MIFEPRISTONE ORAL FORM FOR ITS USE IN CERVIX RIPENING AND LABOUR INDUCTION

CERTAIN N-(1-CYAN0-2-PHENYLETHYL]-1,4-OXAZEPANE-2-CARBOXAMIDES FOR TREATING HIDRADENITIS SUPPURATIVA

TAUROLIDINE TREATMENT FOR MYC-EXPRESSING TUMORS IN MAMMALIAN BODIES

LYSOSOMAL DYSFUNCTION IN NEUROLOGICAL AND PSYCHIATRIC DISORDERS

PYRUVATE KINASE ACTIVATORS FOR USE IN TREATING BLOOD DISORDERS

TREATMENT OF PSYCHIATRIC OR NEUROLOGICAL DISORDERS IN PATIENTS WITH PROMINENT ANHEDONIA USING IRDABISANT AS A MONOTHERAPY OR IN COMBINATION WITH AN ANTIPSYCHOTIC AGENT

COMPOSITION AND METHOD FOR TREATMENT OF DEPRESSION AND PSYCHOSIS IN HUMANS

USE OF VE607 FOR THE TREATMENT OF SARS-COV-2 INFECTIONS AND RELATED DISEASES

ENHANCEMENT OF TUMOR RESPONSE TO CHEMOTHERAPY BY ACTIVATION OF THE ASMASE/CERAMIDE PATHWAY THROUGH TIMED ADMINISTRATION OF A SHORT-ACTING ANTI-ANGIOGENIC AGENT

PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER COMPRISING OMEPRAZOLE BROWNING MATTER

DUAL INHIBITORS OF TIM-3 AND PD-1 PATHWAYS

METHODS OF INHIBITING TUMOR METASTASIS

GLUCONIC ACID DERIVATIVES FOR USE IN THE TREATMENT AND/OR PREVENTION OF MICROBIAL INFECTIONS

PERSONALIZED STARVATION THERAPY FOR CANCER

METHODS OF TREATING MIXED DYSLIPIDEMIA

GUANIDINOACETIC ACID, ITS DERIVATES, COMPOSITIONS AND METHODS OF USE THEREOF

SMALL MOLECULE STAT3 INHIBITOR FOR TREATING TRIPLE NEGATIVE BREAST CANCER

MULTIDRUG PAIN MANAGEMENT PACKAGE

AMINOTHIOL-CONJUGATES, COMPOSITIONS, AND METHODS OF USE THEREOF

COMPOSITIONS COMPRISING SURFACE MODIFIED GLOBULAR NANO-PARTICLES

Method of Increasing Epithelial Permeability Using Nanoparticles

METHOD FOR CARTILAGE REGENERATION AND REGROWTH FOLLOWING INJURY

Mycophenolate Oral Suspension

VETERINARY USE AND DELIVERY OF AMMONIA OXIDIZING MICROORGANISMS

METHOD FOR DIAGNOSING COLLAGEN DEGRADATION ASSOCIATED DISEASE

METHODS FOR THE DETECTION AND TREATMENT OF OVARIAN CANCER

IMMUNOTHERAPY TARGETING

SPLICE-SWITCHING OLIGONUCLEOTIDES AND METHODS OF USE

CHANNEL MODULATORS

NUCLEIC ACIDS FOR INHIBITING EXPRESSION OF COMPLEMENT FACTOR B (CFB) IN A CELL

NK CELLS WITH AN INCREASED ANTIBODY-DEPENDENT CELLULAR TOXICITY (ADCC) AGAINST TUMORS

NOVEL TUMOR-SPECIFIC ANTIGENS FOR COLORECTAL CANCER AND USES THEREOF

ANTI-TMPRSS6 ANTIBODIES AND USES THEREOF

ANTI-HER2 ANTIBODIES AND METHODS OF USE THEREOF

ANTI-CD73 ANTIBODIES AND USE THEREOF

Methods For Prevention Of Graft Rejection In Xenotransplantation

COMPOSITIONS FOR AND METHODS OF TREATING HEMATOLOGICAL CANCERS

OPTIMIZATION OF ANTIBODIES THAT BIND LYMPHOCYTE ACTIVATION GENE-3 (LAG-3), AND USES THEREOF

Method of modulating autoimmunity by disrupting cis-ligand binding of siglec type antigens

ANTI-SIGLEC-3 ANTIBODIES, PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME, AND USES THEREOF

ANTI-ANGPTL3 ANTIBODIES AND USES THEREOF

CD95 POLYPEPTIDES

COMPOSITIONS AND METHODS FOR DNA BINDING AND TRANSCRIPTIONAL REGULATION

SMALL MOLECULE INHIBITORS OF KRAS PROTEINS

4H-PYRROLO[3,2-C]PYRIDIN-4-ONE COMPOUNDS

COMPOUNDS AND METHODS OF USE

C-LINKED INHIBITORS OF ENL/AF9 YEATS

INDOLINONE DERIVATIVES AS INHIBITORS OF MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE

NOVEL MODULATORS OF THE ARYL HYDROCARBON RECEPTOR AND METHODS OF USE THEREOF

COMPOSITIONS, SYSTEMS, AND METHODS FOR TREATING CANCER USING TUMOR TREATING FIELDS WITH INHIBITORS OF MIF, MICA, AND/OR MICB

IODIDE NANOPARTICLES AND COMPOSITIONS OF METHODS OF USE THEREOF

INJECTION OF SINGLE-STRANDED OR SELF-COMPLEMENTARY ADENO-ASSOCIATED VIRUS 9 INTO THE CEREBROSPINAL FLUID

SPLICING MODULATOR ANTIBODY-DRUG CONJUGATES AND METHODS OF USE

CONCATEMERIC PEPTIDE EPITOPE RNAS

METHODS AND SYSTEMS FOR INDUCING APOPTOSIS OF ADIPOSE CELLS

COMPOSITIONS FOR AND METHOD OF EFFECTING TUMOR CELL DEATH

TREATMENT OF HODGKIN LYMPHOMA USING AN ANTI-PD-1 ANTIBODY

USE OF NOVEL POLYMER FOR PREVENTING SARS-COV-2

COMPOSITIONS FOR INDUCING INTRATUMORAL IMMUNE TRIADS AND USES THEREOF

ORAL FORMULATION FOR ACTIVATION OF AUTOLOGOUS STEM CELLS

GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR-BASED TREATMENTS FOR NEURODEGENERATIVE OR NEUROLOGICAL DISEASES OR DISORDERS

TARGETED OESOPHAGEAL ADMINISTRATION OF ZN-ALPHA2-GLYCOPROTEINS (ZAG), METHODS AND FORMULATIONS THEREOF

TRI-, TETRA AND PENTAPEPTIDES, COMPOSITIONS THEREOF AND THEIR USE IN THE THERAPY OF PSORIASIS

HSV-1 ONCOLYTIC VIRUS THERAPIES THAT SPECIFICALLY KILL ALT DEPENDENT CANCERS

IMPROVED METHODS FOR DECELLULARIZING EXTRACELLULAR MATRIX (ECM) AND PREPARING DECELLULARIZED ECM GELS AND USES THEREOF

PHARMACEUTICAL PREPARATIONS OF HUMAN RPE CELLS AND USES THEREOF

SUPERABSORBENT HYDROGELS WITH LIPASE INHIBITOR

METHODS AND SYSTEMS FOR INDUCING APOPTOSIS OF ADIPOSE CELLS

COMPOSITIONS COMPRISING COCRYSTALS OF ACETYLSALICYLIC ACID AND THEANINE WITH TROMETHAMINE AND METHODS OF USE

COMPOSITIONS AND METHODS FOR TREATING LYSOSOMAL DISORDERS

COMPOSITION FOR TREATING CORONAVIRUS DISEASE 2019 (COVID-19) CONTAINING TAURODEOXYCHOLIC ACID OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AND ANTIVIRAL AGENT AS ACTIVE INGREDIENTS

THERAPEUTICS AND METHOD FOR TREATING OSTEOARTHRITIS

DRUG REPURPOSING FOR DELAYED TREATMENT OF ISCHEMIC STROKE

COMBINATION OF COMPOUNDS FOR TREATING VASCULAR DISEASES COMPRISING PDE5 INHIBITOR, ARGININE AND N-ACETYLCYSTEINE

PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND USES THEREOF

C-MET MODULATOR PHARMACEUTICAL COMPOSITIONS

METHODS OF TREATING CANCER DEPENDENT ON MYC GENE EXPRESSSION

METHODS OF TREATING A CANCER OVEREXPRESSING ONE OR MORE BCL-2 FAMILY PROTEINS

ANTITUMOR COMPOSITION

INHIBITORS OF SHORT-CHAIN DEHYDROGENASE ACTIVITY FOR MODULATING HEMATOPOIETIC STEM CELLS AND HEMATOPOIESIS

NOVEL COMPOUND, AND COMPOSITION FOR PREVENTING, ALLEVIATING OR TREATING BACTERIAL INFLAMMATION AND INFLAMMASOME-MEDIATED DISEASES, COMPRISING SAME AS ACTIVE INGREDIENT

COMPOSITIONS AND METHODS FOR TREATMENT OF NAFLD AND NASH AND RELATED DYSLIPIDEMIAS

METHOD OF ADMINISTRATION OF BRYOSTATIN FOR THE INDUCTION OF TUMOR ASSOCIATED ANTIGENS

Fumaric Acid Esters, Inhalation Administration Methods, Pharmaceutical Uses and Compositions

MUCO-ADHESIVE, CONTROLLED RELEASE FORMULATION OF LEVODOPA AND/OR ESTERS OF LEVODOPA AND USES THEREOF

TOPICAL DIM COMPOSITIONS AND USES THEREOF

NOVEL METHODS FOR DECELLULARIZING EXTRACELLULAR MATRIX

COMPOSITIONS AND PROCESSES FOR TARGETED DELIVERY, EXPRESSION AND MODULATION OF CODING RIBONUCLEIC ACIDS IN TISSUE

Treatment Of Osteoarthritis With Procollagen Galactosyl Transferase 2 (COLGALT2) Inhibitors

Treatment Of Macular Degeneration With Complement Factor D (CFD) Inhibitors

METHOD FOR REDUCING HEPATIC TRIGLYCERIDES

Treatment Of Liver Disease Or Metabolic Disorder With Folliculin Interacting Protein 1 (FNIP1) Inhibitors And/Or Folliculin (FLCN) Inhibitors

BUTYROPHILIN (BTN) 3A ACTIVATING ANTIBODIES FOR USE IN METHODS FOR TREATING INFECTIOUS DISORDERS

DOSING FOR TREATMENT WITH ANTI-FCRH5/ANTI-CD3 BISPECIFIC ANTIBODIES

Method of Treating Psoriasis with Anti-IL23 Specific Antibody

PEPTIDE COMPOUNDS TO REGULATE THE COMPLEMENT SYSTEM

METHODS FOR TREATMENT OF CANCER

C-MYC MRNA TRANSLATION MODULATORS AND USES THEREOF IN THE TREATMENT OF CANCER

BICYCLIC HETEROARYLAMINOALKYL PHENYL DERIVATIVES AS PI3K INHIBITORS

RAS INHIBITORS

Compounds

4-(2-PYRAZOLO[3,4-B]PYRIDINE-5-YL)ETHYNYL-2-PYRIDINE DERIVATIVES USEFUL AS GCN2 INHIBITORS

PLATELET-DERIVED GROWTH FACTOR RECEPTOR (PDGFR) ALPHA INHIBITORS AND USES THEREOF

PRODRUGS OF 2-BROMO-LSD (2-BROMOLYSERGIC ACID DIETHYLAMIDE)

BENZOTHIAZOLE COMPOUNDS AS VHL LIGANDS

SUBSTITUTED PHENYL OXAZOLONE COMPOUNDS

PRODRUGS OF 3,4-METHYLENEDIOXY-N-METHCATHINONE AND USES THEREOF

1H-PYRAZOLE-3-AMINE DERIVATIVE HAVING BICYCLIC BACKBONE

SMALL MOLECULE PIM AND MTOR KINASE INHIBITOR AND METHODS OF USE THEREOF

COMPOUNDS AND METHODS FOR YAP/TEAD MODULATION AND INDICATIONS THEREFOR

TRYPTAMINE DERIVATIVES

GAMMA-D POLYGLUTAMATED ANTIFOLATES AND USES THEREOF

ANTI-CLDN-18.2 ANTIBODY-DRUG CONJUGATE AND USE THEREOF

EGFR TARGETED THERAPY

TREATMENT OF AUTOIMMUNE ENCEPHALITIS WITH SATRALIZUMAB

COMPOSITIONS AND METHODS FOR TREATING CORONAVIRUS INFECTIOUS DISEASE-19 (COVID-19)

Hyaluronidase Enzyme Formulations for High Volume Administration

Hyaluronidase Enzyme Formulations for High Volume Administration

INSULIN FORMULATIONS AND USES IN INFUSION DEVICES

COMBINED PREPARATIONS FOR THE TREATMENT OF CANCER

POLYPEPTIDES FOR TREATMENT OF CANCER

CYTOKINE MODULATION

MEDICINAL USES OF OLIGOPEPTIDES IN COMBINATION WITH AN ANTIANDROGEN

DUAL ACTING POLYMERS IN AN OSMOTIC FILM FOR TOPICAL APPLICATION TO TREAT INFLAMMATORY DISEASES AND CYTOKINE RELEASE SYNDROME

COMPOSITION FOR TREATMENT OF TOPICAL DERMATOLOGICAL BACTERIAL SKIN CONDITIONS

BACILLUS VELEZENSIS STRAINS AND COMPOSITION FOR PREVENTING, TREATING, OR IMPROVING TUBERCULOSIS COMPRISING THE SAME

BACTERIAL STRAIN USED IN THE PREVENTION AND/OR TREATMENT OF INFLAMMATORY PATHOLOGIES

BOREALIN TARGETING POLYPEPTIDES FOR DETECTION AND TREATMENT OF CANCER

METHOD FOR TREATING PERIODONTAL DISEASE

BRIDGED TRICYCLIC CARBAMOYLPYRIDONE COMPOUNDS AND USES THEREOF

METHODS OF TREATING CANCER WITH PI3K INHIBITOR, GDC-0077

METHODS OF TREATING CANCER

USE OF INHIBITORS OF BRUTON'S TYROSINE KINASE (BTK)

METHOD OF INDUCING DENDRITIC AND SYNAPTIC GENESIS IN NEURODEGENERATIVE CHRONIC DISEASES

METHODS OF DIAGNOSING AND TREATING TOURETTE SYNDROME

THERAPEUTIC TARGETING OF INOSITOL PYROPHOSPHATE SYNTHESIS IN CANCER

Roflumilast Formulations with an Improved Pharmacokinetic Profile

ISOTHIOCYANATE FUNCTIONAL COMPOUNDS AUGMENTED WITH SECONDARY ANTINEOPLASTIC MEDICAMENTS AND ASSOCIATED METHODS FOR TREATING NEOPLASMS

USE OF BRANCHED CHAIN FATTY ACIDS (BCFAS) FOR THE TREATMENT OF INTESTINAL INFLAMMATION

METHODS FOR TREATING NEUROBLASTOMA

NOVEL NAPROXEN SODIUM PREPARATIONS FOR PARENTERAL ADMINISTRATION

BUTYRATE AND BETA-HYDROXYBUTYRATE COMPOSITIONS

METHODS OF PERMEABILIZING THE BLOOD BRAIN BARRIER

TOPICAL FORMULATIONS FOR TREATING DERMATOLOGICAL DISORDERS INCLUDING MALE PATTERN BALDNESS

ORAL COMPOSITION OF CELECOXIB FOR TREATMENT OF PAIN

DEPLETION OF FNDC5 REDUCES CANCER INDUCED MUSCLE LOSS/CACHEXIA

BISPECIFIC ANTIGEN BINDING CONSTRUCTS TARGETING HER2

METHOD OF TREATMENT OF PHILADELPHIA CHROMOSOME POSITIVE LEUKEMIA

ANTI-Ly6E ANTIBODIES, IMMUNOCONJUGATES, AND USES THEREOF

ANTI-INTERLEUKIN-9 ANTIBODY AND USE THEREOF

BTNL3/8 TARGETING CONSTRUCTS FOR DELIVERY OF PAYLOADS TO THE GASTROINTESTINAL SYSTEM

METHODS OF TREATING CANCERS WITH CT45 TARGETED THERAPIES

METHOD FOR PRODUCING AN ANTITUMORAL ARENAVIRUS AS WELL AS ARENAVIRUS MUTANTS

HETEROCYCLIC COMPOUNDS AS UBIQUITIN SPECIFIC PROTEASE 7 INHIBITORS

BRIDGED TRICYCLIC CARBAMOYLPYRIDONE COMPOUNDS AND USES THEREOF

CHEMOKINE RECEPTOR MODULATORS AND USES THEREOF

NOVEL PYRIDOCARBAZOLIUM COMPOUNDS AND MEDICAL USES THEREOF

ANTI-BIOFILM COMPOUNDS

COMPOSITIONS AND METHODS COMPRISING SUBSTITUTED N-(2-CHLORO-6-METHYLPHENYL)-2-((6-(6-MEMBERED HETEROCYCLOALKYL)-2-METHYLPYRIMIDIN-4-YL)AMINO)THIAZOLE-5-CARBOXAMIDE ANALOGUES

Heteroaryl Compounds As HPK1 Inhibitors And Methods Of Using Same

Pyrazine Compounds Useful in the Treatment of Parasitic Protozoal Infection

N,N-DIMETHYLAMPHETAMINE ANALOGS FOR TREATING BRAIN DISORDERS

CRYSTALLINE QUATERNARY SALTS OF 4-SUBSTITUTED TRYPTAMINES

COMPOSITIONS AND METHODS FOR ADHESION TO SURFACES

EGFR-CMET-TARGETED COMPOUNDS AND USES THEREOF

ALPHA-FETOPROTEIN BIOCONJUGATES FOR DISEASE TREATMENT

Subcutaneous anti-HER2 Antibody Formulations and Uses Thereof

COMBINATION THERAPY WITH AN ANTI-HER2 ANTIBODY-DRUG CONJUGATE AND A BCL-2 INHIBITOR

COMBINATION THERAPIES FOR TREATING CANCERS

INTERFERON- INDUCING COMPLEXES AND RNA DUPLEXES AND METHODS OF USE

HIV PRE-IMMUNIZATION AND IMMUNOTHERAPY

MRNA THERAPEUTIC COMPOSITIONS

STABILIZED PHARMACEUTICAL FORMULATIONS OF INSULIN ANALOGUES AND/OR INSULIN DERIVATIVES

METHODS OF TREATING CHEMOTHERAPY INDUCED NEUTROPENIA USING FIXED DOSES OF G-CSF PROTEIN COMPLEX

COMPOSITIONS AND USES OF ANTIMICROBIAL MATERIALS WITH TISSUE-COMPATIBLE PROPERTIES

ONCOLYTIC VIROTHERAPY COMPOSITIONS AND METHODS

USE OF BACILLUS AMYLOLIQUEFACIENS FOR PREVENTING AND TREATING PARKINSON'S DISEASE

DEVELOPING INDUCIBLE CLUSTER CHIMERIC ANTIGEN RECEPTOR (CCAR) CONSTRUCTS

SYSTEMS AND METHODS USING SULFATED GLYCOSAMINOGLYCANS (GAGs) AND GAG ANALOGS TO TREAT OR PREVENT MONKEYPOX (MPOX)

AZITHROMYCIN AND ROXITHROMYCIN DERIVATIVES AS SENOLYTIC DRUGS

BRIDGED TRICYCLIC CARBAMOYLPYRIDONE COMPOUNDS AND USES THEREOF

METHODS FOR TREATING SUBJECTS WITH PRADER-WILLI SYNDROME OR SMITH-MAGENIS SYNDROME

TYROSINE KINASES INHIBITORS AND USES THEREOF

ANTI-AGEING SUPPLEMENT

METHODS AND COMPOSITIONS FOR THE TREATMENT OF THROMBOCYTOPENIA

NONSELECTIVE METABOTROPIC GLUTAMATE RECEPTOR ACTIVATORS FOR TREATMENT OF ATTENTION DEFICIT DISORDER AND 22Q SYNDROME

Treatment of GM2 Gangliosidosis

TREATMENT OF NEUROPSYCHIATRIC DISORDERS WITH TILIVAPRAM

CLEMIZOLE FORMULATION

USE OF SPLA2 INHIBITORS TO TREAT HYMENOPTERA ENVENOMATION, HEMOLYSIS, AND KIDNEY DISEASE, AND TO PROTECT BLOOD FROM OSMOTIC FRAGILITY

USE OF SPLA2 INHIBITORS TO TREAT ENVENOMATION BY SNAKES AND WASPS

COMPOUNDS AND METHODS TO SENSITIZE CANCER CELLS TO CISPLATIN

METHODS OF IMPROVING RENAL FUNCTION

THERAPEUTICS AND METHOD FOR TREATING OSTEOARTHRITIS

GEL BASE COMPOSITION FOR COMPOUNDING INTO A MUCOADHESIVE DELIVERY SYSTEM

Transmucosal Drug Delivery System

THERAPEUTIC AGENTS TARGETING THE LYMPHATIC SYSTEM

Device And Method For Stimulating The Meibomian Glands Of The Eyelid

PHOSPHOPEPTIDE/PHOSPHOPROTEIN SIGNATURE PREDICTING BASAL-LIKE BREAST CANCER RECURRENCE

CHLOROTOXIN CONJUGATES AND METHODS OF USE THEREOF

COMPOUNDS CONTAINING DEUTERIUM

PHOTODYNAMIC THERAPY AND DIAGNOSIS

BRIDGED TRICYCLIC CARBAMOYLPYRIDONE COMPOUNDS AND USES THEREOF

DIARYL COMPOUND AS TUBULIN/SRC DUAL TARGET INHIBITOR

HETEROCYCLIC GLP-1 AGONISTS

INHIBITORS OF HYPOXIA-INDUCIBLE FACTORS

Polymorphisms of HM30181 Mesylate

MOLECULAR GLUE DEGRADERS AND METHODS OF USING THE SAME

OXOPIPERAZINE DERIVATIVES

cGAS ANTAGONIST COMPOUNDS

MODULATORS OF THE INTEGRATED STRESS PATHWAY

BIPHENYL-SUBSTITUTED EPITHELIAL SODIUM CHANNEL BLOCKING COMPOUNDS

LINKERS FOR ANTIBODY DRUG CONJUGATES

COMBINATION TREATMENT OF TUMORS

ANTI-DLL3 ANTIBODY AND PREPARATION METHOD THEREFOR, DRUG CONJUGATE AND APPLICATION THEREOF

VISTA ANTAGONIST AND METHODS OF USE

COLLAGEN HYDROLYSATE COMPOSITION FOR REDUCING JOINT PAIN AFTER EXERCISE

ANTIMICROBIAL NATURAL COMPOSITIONS

INTESTINAL HEALTH PROMOTING COMPOSITIONS

AMMONIA OXIDIZING MICROORGANISMS FOR THE TREATMENT OF DIAPER RASH, ATHLETE’S FOOT, CONTACT DERMATITIS, PERSPIRATION, AND BODY ODOR

METHODS AND COMPOSITIONS HIGH SCALE THERAPEUTIC PRODUCTION OF MEMORY NK CELLS

COMPOSITIONS INCORPORATING SULFATED POLYSACCHARIDES FOR INHIBITING SARS-COV-2

CANCER TREATMENT REGIMEN USING ANTI-PARASITIC COMPOUNDS AND GUT MICROBIOME MODULATING AGENTS

BETA-GLUCAN IN COMBINATION WITH ANTI-CANCER AGENTS AFFECTING THE TUMOR MICRENVIRONMENT

NUCLEOSIDES AND NUCLEOTIDES ANALOGS AS ANTIVIRAL AGENTS

COMBINATION OF A GLYCOSYLATION INHIBITOR WITH ONE CAR CELL THERAPY FOR TREATING CANCER

BIOMARKER AND PATIENT SELECTION IN TREATMENT FOR MYELOFIBROSIS

METHODS AND COMPOSITIONS FOR TREATMENT OF CUTANEOUS PROLIFERATIVE DISORDERS AND OTHER SKIN CONDITIONS

INDAZOLE BASED COMPOUNDS AND ASSOCIATED METHODS OF USE

Treatment of Bronchiectasis

TETRAHYDRO-PYRIDO[3,4-b]INDOLE ESTROGEN RECEPTOR MODULATORS AND USES THEREOF

METHODS FOR VASCULAR REGENERATION AND WOUND TREATMENT

CONCURRENT TARGETING OF ONCOGENIC PATHWAYS TO ENHANCE CHEMOTHERAPY AND IMMUNOTHERAPY

METHODS FOR TREATING AML-MRC AND MDS

USE OF ATRACTYLENOLIDE I IN PREPARATION OF MEDICINE FOR PREVENTING AND/OR TREATING CERVICAL CANCER

ANTIMICROBIAL MATERIALS AND NANOPARTICLES AND METHODS OF USE THEREOF

METHODS AND COMPOSITIONS FOR TREATING SLEEP APNEA

TREATMENT OF COPPER DISORDERS

METHOD OF DELIVERY OF DNA OR RNA CARGO USING UNSHIELDED LIPID NANOPARTICLES AND COMPOSITIONS THEREOF

METHODS OF IDENTIFYING SUBJECTS RESPONSIVE TO TREATMENT FOR AN AUTOIMMUNE DISEASE AND COMPOSITIONS FOR TREATING THE SAME

DNA HYPOMETHYLATION AS A PREDICTIVE MARKER FOR CANCER THERAPY

METHOD FOR PRODUCING MEMORY-LIKE NATURAL KILLER CELLS AND ANTICANCER USE OF MEMORY-LIKE NATURAL KILLER CELLS PRODUCED THEREBY